Microcirculation, Pregnancy
Conditions
Brief summary
This is an observational study comparing microcirculation of pregnant to non-pregnant women. Microcirculation means blood flow to the extremely small blood vessels in one's body. During pregnancy the amount of blood in a woman's body increases. The body responds to this increase by pumping more blood through the heart and narrowing the size of blood vessels. There are many types of blood vessels that have different roles in the body. Larger blood vessels. Transport blood to and from body organs like the brain and liver. Small vessels (microcirculation)distributes blood to the organ tissues. The microcirculation can change blood flow and blood pressure. Microcirculation is involved in delivering oxygen and nutrients to your body, removing waste products, and regulating body temperature. The investigators current understanding of the microcirculation in pregnant women is limited. There is a device available that can measure microcirculation. It is known as Sidestream Dark Field (SDF) imaging. It is a special type of camera that captures pictures of the microcirculation. In this study the investigators will compare the microcirculation, as seen with SDF imaging, of pregnant women to non-pregnant women. By improving the investigators understanding of maternal microcirculation the investigators are adding to the knowledge of how the pregnant body works. The investigators hope to then translate this knowledge into further studies to improve maternal and fetal outcomes through prevention and treatment of maternal low blood pressure caused by spinal anesthesia.
Detailed description
The objectives of this observational trial are; to compare the sublingual microcirculation of pregnant subjects to that of comparable non-pregnant volunteers; to evaluate the usefulness of a non-invasive technology, SDF imaging in pregnant and non-pregnant subjects. By improving our understanding of maternal microcirculation we not only add to the knowledge of maternal physiology, we hope to then translate this knowledge into further studies to improve maternal and fetal clinical outcomes through prevention and treatment of maternal hypotension especially in relation to spinal anesthesia.
Interventions
None listed
Sponsors
IWK Health Centre
Study design
Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
FEMALE
Healthy volunteers
Yes
Inclusion criteria
* American Society of Anesthesiologists (ASA) Physical Status I-II (ASA I Healthy, ASA II - mild and controlled systemic disease) * Pregnant: singleton, 36 - 40 weeks EGA, non-labouring * Non- Pregnant - Healthy female volunteers who have never been pregnant, matched to pregnant patients for age ± 1 year
Exclusion criteria
* Obesity (BMI \> 35 kg/m2) * Hypertensive disease (Essential, gestational, or preeclampsia) * Diabetes Mellitus Type 1 * Cardiovascular disease * Smoker (1 cigarette or other tobacco product within 12 months) * Caffeinated (i.e. coffee, tea, energy drink) beverage with 2 hours
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Microvascular Flow Index (MFI) | 1 yr | The primary outcome is the difference between the MFI of pregnant versus non-pregnant subjects. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| PVD | 1 yr | Perfused vessel density |
| PPV | 1 yr | Proportion of perfused vessels |
Countries
Canada
Outcome results
None listed